sale y/i pro forma lag our/street
estim versu estim line csi lower
primarili owe flat y/i paragard sale oper margin line
think lower sg offset lower gm ep exceed our/street
estim lower tax rate higher incom tighten
annual sale guidanc ep guidanc
rais lower end primarili lower tax rate
manag sound optimist around potenti fda updat misight year-
end continu target low-double-digit constant-curr oper
grew pf led shift daili particularli silicon hydrogel
clariti/myday misight myopia control fda
discuss misight us continu manag note potenti
meaning updat year-end asiapac led america
emea slow vs inventori destock
surgic grew pf paragard came lower flat y/i despit continu
asp improv manag note paus televis advertis
physician inventori contract driver continu target mid-
singl digit paragard growth next sever year unit growth
potenti advertis posit price
remain focus drive growth key account global
retailer/region chains/buy group invest sales/advertising/
promot convert/dr new wearer growth gm impact
higher secondari handl cost given transfer new costa rica facil
off-set improv fertil busi improv expect
reduc fx rebat headwind
guidanc sale guidanc pf assum growth
csi estim fx sales/ep headwind larg
ep guidanc rais low end
primarili lower tax rate year manag
target tax rate option exercis
estim lower sale slightli cc
lower multifoc len paragard estim ep increas
lower tax rate forecast sales/ep
higher tax rate partial off-set ep
recent peer multipl expans price target rise
year price histori
cooper compani global
medic devic compani focus
primarili
develop
market soft contact lens
compani also market varieti
surgic instrument
analyst certif import disclosur see disclosur
target price estim cash
ep line peer current trail multipl
competit stiffen contact len market estim
above-market contact len growth driven
compani specialti len offer increas silicon
term sale growth paragard rate share perform
valuat
grow ahead market constant currenc
oper margin flat y/i includ headwind fx
impact ep
len market grow next five year
fda updat misight estim year-end
impact paraguard channel invest
upsid paragard channel invest
better expect margin expans
quicker expect misight contribut
larger impact competitor product rollout
lower expect gross margin leverag
price target impli approxim multipl ep estim previous peer multipl expans
line peer group current-trail multipl
risk includ daili market growth slow competit increas lower expect gross margin leverag
non single-us sphere
non single-us sphere
